Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,705,573
+$47,037 QoQ
Shares Held
10,233
-1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#972
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA FINANCIAL ADVISORS LLC holds $17,401,793 across 7 Drug Manufacturers - General names. AMGN ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,593 | $6,499,854 | |
| 2 | AMGN |
Amgen Inc
This page
|
10,233 | $3,705,573 | |
| 3 | ABBV |
AbbVie Inc.
|
9,464 | $2,381,520 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,179 | $2,079,001 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,459 | $1,524,567 | |
| 6 | PFE |
Pfizer Inc
|
25,454 | $612,932 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,736 | $598,346 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,705,573 | 10,233 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,658,536 | 10,398 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,371,620 | 10,301 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,792,086 | 9,894 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $2,721,739 | 9,748 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,972,187 | 9,540 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,473,473 | 9,490 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $3,048,106 | 9,460 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,950,465 | 9,443 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,680,568 | 9,428 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,673,401 | 9,282 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,657,498 | 9,888 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $2,181,790 | 9,827 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,269,549 | 9,388 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,535,789 | 9,655 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,173,081 | 9,641 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $2,297,481 | 9,443 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,291,969 | 9,478 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,142,164 | 9,522 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,126,074 | 9,998 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,413,125 | 9,900 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,303,234 | 9,257 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,124,690 | 9,241 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $2,376,396 | 9,350 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $2,313,314 | 9,808 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $2,054,871 | 10,136 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||